Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

How Celgene Could Reap Huge Rewards From This Tiny Biotech

  • Post author:Sam
  • Post published:November 16, 2017
  • Post category:BioPharma

Celgene loves cozying up to emerging biotech stocks working on next-generation medicine, and one of those collaborations is with Jounce Therapeutics. Source: BioSpace

Continue ReadingHow Celgene Could Reap Huge Rewards From This Tiny Biotech

Meet the 6 Powerful Bay Area Biotech VCs You've Never Heard About

  • Post author:Sam
  • Post published:November 16, 2017
  • Post category:BioPharma

A look at six bay area-based VCs who are creating a lot of value in biotech. Source: BioSpace

Continue ReadingMeet the 6 Powerful Bay Area Biotech VCs You've Never Heard About

Why Gilead Should Keep an Eye on Juno's New CAR-T Strategy

  • Post author:Sam
  • Post published:November 16, 2017
  • Post category:BioPharma

CAR-T is a hot new area and there are companies hot on Gilead's tail, namely Juno, in a partnership with Celgene, and Novartis. Source: BioSpace

Continue ReadingWhy Gilead Should Keep an Eye on Juno's New CAR-T Strategy

SEC Filings Reveal GlaxoSmithKline's 13% Stake in This Massachusetts Biotech

  • Post author:Sam
  • Post published:November 16, 2017
  • Post category:BioPharma

A filing with the SEC indicates that Glaxo now has a 13 percent stake in Spero Therapeutics. Source: BioSpace

Continue ReadingSEC Filings Reveal GlaxoSmithKline's 13% Stake in This Massachusetts Biotech

Merit Medical Coughs Up $100M for Bard, BD's Biopsy Assets

  • Post author:Sam
  • Post published:November 15, 2017
  • Post category:BioPharma

Shares of Merit Medical Systems have jumped more than 9 percent this morning after the company announced it plunked down $100M for two product lines belonging to Becton, Dickinson and…

Continue ReadingMerit Medical Coughs Up $100M for Bard, BD's Biopsy Assets

FDA Berates Lupin for Repeatedly Making Pills That Don't Meet Quality Standards

  • Post author:Sam
  • Post published:November 15, 2017
  • Post category:BioPharma

In 2015 and 2016, the FDA found 134 instances when drugs or active ingredients failed initial testing but the company chose to override the results. Source: BioSpace

Continue ReadingFDA Berates Lupin for Repeatedly Making Pills That Don't Meet Quality Standards

With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial

  • Post author:Sam
  • Post published:November 15, 2017
  • Post category:BioPharma

Moderna announced that it has dosed its first patient in a Phase I trial of mRNA-4157, a mRNA-based personalized cancer vaccine. Source: BioSpace

Continue ReadingWith Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial

Johns Hopkins Gets a $65M Boost to Take Promising Drugs Into Clinic

  • Post author:Sam
  • Post published:November 15, 2017
  • Post category:BioPharma

Deerfield and Johns Hopkins announce Bluefield Innovations, a collaboration designed to catalyze the development of early stage therapeutics. Source: BioSpace

Continue ReadingJohns Hopkins Gets a $65M Boost to Take Promising Drugs Into Clinic

Verily Ranked #1 for Interesting & Meaningful Work and Competitive Salary

  • Post author:Sam
  • Post published:November 15, 2017
  • Post category:BioPharma

The opportunity to work at the leading edge of science and technology while working on solutions to some of the world's most vexing problems is what attracts people to Verily.…

Continue ReadingVerily Ranked #1 for Interesting & Meaningful Work and Competitive Salary

Regeneron Gets OK for Huge Expansion in Greenburgh, New York

  • Post author:Sam
  • Post published:November 15, 2017
  • Post category:BioPharma

When complete, the expansion is expected to double the size of Regeneron's footprint in Greenburgh. Source: BioSpace

Continue ReadingRegeneron Gets OK for Huge Expansion in Greenburgh, New York
  • Go to the previous page
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.